{"version":"1.0","type":"link","title":"Comparative disproportionality analysis of adverse events associated with combined therapy versus monotherapy of abiraterone and olaparib for prostate cancer: a pharmacovigilance study using the FAERS database.","author_name":"Zhang SH 외","author_url":"https://prs-insight.online/author/Zhang%20SH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138271","thumbnail_width":1200,"thumbnail_height":630}